Baxter, D. (2007) Active and passive immunity, vaccine types, excipients and licensing. Occup Med (Lond). 57: 552-56.
Bayat, E., Kamali, M., Zareei Mahmoodabadi, A., Mortazavi, Y., Ebrahim Habibi, A., Amini, B., Javadi, H.R., Farhadi, N., Faghihi, H. (2010) Isolation, determination and cloning of translocation domain of exotoxin A from Pseudomonas aeruginosa. Kowsar Medical Journal. 15: 149-54.
Chen, T.Y., Lin, C.P., Loa, C.C., Chen, T.L., Shang, H.F., Hwang, J., Hui, C.F. (1999) A nontoxic Pseudomonas aeruginosa exotoxin A induces active Immunity and passive protective antibody against Pseudomonas exotoxin A intoxication. J Biomed Sci. 6: 357-63.
Denis-Mize, K.S., Price, B.M., Baker, N.R., Galloway, D. (1999) Analysis of Immunization with DNA encoding Pseudomonas aeruginosa exotoxin A. FEMS Immunol Med Microbiol. 27: 147- 54.
Fujimura, T., Suzuki, T., Mitsuyama, M, Saito, H., Nomoto, K. (1989) Antibody independent Protection against Pseudomonas aeruginosa infection in mice after treatment with a homologus strain vaccine. J Med Microbial. 28: 101-8.
Harkness, J.E. (1993) A practitioners guide to Domestic Rodents. American Animal Hospital Association. Lakewood, USA.
Hertle, R., Mrsny, R., Fitzgerald, D.J. (2001) Dual–function vaccine for Pseudomonas aeruginosa: characterization of chimeric exotoxin A– Pilin Protection. Infect Immun. 69: 6962-69.
Hosseini Jazani, N., Parsania, S., Sohrabpour, M., Mazloomi, E., Karimzad, M., Shahabi, SH. (2010) Naloxone and alum synergistically augment adjuvant activities of each other in a mouse vaccine model of Sallmonella typhimurium infection. Immunobiology. 6: 744-51.
Hung, C.F., Cheng, W.F., Hsu, K.F., Chai, C.Y., He, L., Ling, M., WU, T.C. (2001) Cancer immunotherapy using a DNA vaccine encoding the translocation domain of a bacterial toxin linked to a tumor antigen. Cancer Res. 61: 3698-3703.
Khan, A., Cerniglia, C. (1994) Detection of Pseudomonas aeruginosa from clinical environmental samples by amplification of the exotoxin A gene using PCR. Appl Environ Microbiol. 60: 3739-45.
Kinoshita, M., Shinomiya, N., Ono, S., Tsujmoto, H., Kawabata, T., Matsumoto, A., Hiraide, H., Seki, S. (2006) Restoration of natural IgM production from liver B cells by Exogenous Il-18 improves the survival of burn injured mice infected with Pseudomonas aeruginosa. J Immunol. 177: 4627-35.
Lang, A.B., Horn, M.P., Imboden, M.A., Zuercher, A.W. (2004) Prophylaxis and therapy of Pseudomonas aeruginosa infection in cystic fibrosis and unocompromised patients. Vaccine. 22: S44-S48.
Manafi, A., Kohanteb, J., Mehrabani, D., Japoni, A., Amini, M., Naghmachi, M., Zaghi, A.H., Khalili, N. (2009) Active immunization using exotoxin A confers protection against Pseudomonas aeruginosa infection in mouse burn model. BMC Microbiol. 9: 23-27.
Mcvay, C.S., Velasquez, M., Fralik, J.A. (2007) Phage therapy of Pseudomonas aeruginosa infection in a mouse burn wound model. Antimicrob Agents Chemother. 51: 1934-38.
Nouri Gharajelar, S., Ahmadi, M., Hosseini, B. (2013) Cloning and expression of the immunogenic moiety of Pseudomonas aeruginosa exotoxin A. Biological Journal of Microorganism. 1: 7-14.
Pavlovskis, O.R., Edman, D.C., Leppla, SH., Wretlind, B., Lewis, L.R., Martin, K.E. (1981)Protection against toxoids, experimental Pseudomonas aeruginosa infection in mice by active immunization with Exotoxin A. Infect Immun. 32: 681-89.
Pollack, M. (1983) The role of exotoxin A in Pseudomonas disease And Immunity. Rev Infect Dis. 5: S979-84.
Rumbaugh, K.P., Griswold, J.A., Iglewski, B.H., Hamood, A.N. (1999) Contribution of quorum sensing to the virulence of Pseudomonas aeruginosa in burn wound infections. Infect Immun. 67: 5854-62.
Staczek, J., Gilleland, L.B., Vanderhyde, H.C., Gilleland, J.R. (2003) DNA vaccines against chronic lung infections by Pseudomonas aeruginosa. FEMS Immunol Med Microbiol. 37: 147-53.
Wahren, B., Liu, M.A. (2014) DNA vaccines: Recent developments and the future. Vaccines. 2: 785-796.
Whalen, R.G. (1996) DNA vaccines for emerging infectious diseases. Emerg Infect Dis. 2: 168-175.
)